Retrospective study of the effect of vaccination against SARS-CoV-2 in seriously ill patients admitted to an intensive care unit
Copyright © 2023 Elsevier España, S.L.U. All rights reserved..
BACKGROUND AND OBJECTIVE: Our study aims to compare the clinical and epidemiological characteristics, length of stay in the ICU, and mortality rates of COVID-19 patients admitted to the ICU who are fully vaccinated, partially vaccinated, or unvaccinated.
PATIENTS AND METHODS: Retrospective cohort study (March 2020-March 2022). Patients were classified into unvaccinated, fully vaccinated, and partially vaccinated groups. We initially performed a descriptive analysis of the sample, a multivariable survival analysis adjusting for a Cox regression model, and a 90-day survival analysis using the Kaplan-Meier method for the death time variable.
RESULTS: A total of 894 patients were analyzed: 179 with full vaccination, 32 with incomplete vaccination, and 683 were unvaccinated. Vaccinated patients had a lower incidence (10% vs. 21% and 18%) of severe ARDS. The survival curve did not show any differences in the probability of surviving for 90 days among the studied groups (p = 0.898). In the Cox regression analysis, only the need for mechanical ventilation during admission and the value of LDH (per unit of measurement) in the first 24 hours of admission were significantly associated with mortality at 90 days (HR: 5.78; 95% CI: 1.36-24.48); p = 0.01 and HR: 1.01; 95% CI: 1.00-1.02; p = 0.03, respectively.
CONCLUSIONS: Patients with severe SARS-CoV-2 disease who are vaccinated against COVID-19 have a lower incidence of severe ARDS and mechanical ventilation than unvaccinated patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:161 |
---|---|
Enthalten in: |
Medicina clinica - 161(2023), 5 vom: 08. Sept., Seite 199-204 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
Estudio retrospectivo del efecto de la vacunación frente al SARS-CoV-2 en enfermos graves que ingresan en una unidad de cuidados intensivos |
---|
Beteiligte Personen: |
Rodríguez-Borregán, Juan Carlos [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 04.09.2023 Date Revised 31.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.medcli.2023.04.022 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357470753 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357470753 | ||
003 | DE-627 | ||
005 | 20231226072648.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.medcli.2023.04.022 |2 doi | |
028 | 5 | 2 | |a pubmed24n1191.xml |
035 | |a (DE-627)NLM357470753 | ||
035 | |a (NLM)37244858 | ||
035 | |a (PII)S0025-7753(23)00242-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rodríguez-Borregán, Juan Carlos |e verfasserin |4 aut | |
245 | 1 | 0 | |a Retrospective study of the effect of vaccination against SARS-CoV-2 in seriously ill patients admitted to an intensive care unit |
246 | 3 | 3 | |a Estudio retrospectivo del efecto de la vacunación frente al SARS-CoV-2 en enfermos graves que ingresan en una unidad de cuidados intensivos |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.09.2023 | ||
500 | |a Date Revised 31.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier España, S.L.U. All rights reserved. | ||
520 | |a BACKGROUND AND OBJECTIVE: Our study aims to compare the clinical and epidemiological characteristics, length of stay in the ICU, and mortality rates of COVID-19 patients admitted to the ICU who are fully vaccinated, partially vaccinated, or unvaccinated | ||
520 | |a PATIENTS AND METHODS: Retrospective cohort study (March 2020-March 2022). Patients were classified into unvaccinated, fully vaccinated, and partially vaccinated groups. We initially performed a descriptive analysis of the sample, a multivariable survival analysis adjusting for a Cox regression model, and a 90-day survival analysis using the Kaplan-Meier method for the death time variable | ||
520 | |a RESULTS: A total of 894 patients were analyzed: 179 with full vaccination, 32 with incomplete vaccination, and 683 were unvaccinated. Vaccinated patients had a lower incidence (10% vs. 21% and 18%) of severe ARDS. The survival curve did not show any differences in the probability of surviving for 90 days among the studied groups (p = 0.898). In the Cox regression analysis, only the need for mechanical ventilation during admission and the value of LDH (per unit of measurement) in the first 24 hours of admission were significantly associated with mortality at 90 days (HR: 5.78; 95% CI: 1.36-24.48); p = 0.01 and HR: 1.01; 95% CI: 1.00-1.02; p = 0.03, respectively | ||
520 | |a CONCLUSIONS: Patients with severe SARS-CoV-2 disease who are vaccinated against COVID-19 have a lower incidence of severe ARDS and mechanical ventilation than unvaccinated patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Cuidados intensivos | |
650 | 4 | |a Intensive care unit | |
650 | 4 | |a Mechanical ventilation | |
650 | 4 | |a Mortalidad | |
650 | 4 | |a Mortality | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Vaccination | |
650 | 4 | |a Vacunación | |
650 | 4 | |a Ventilación mecánica | |
700 | 1 | |a Cuenca-Fito, Elena |e verfasserin |4 aut | |
700 | 1 | |a Peñasco, Yhivian |e verfasserin |4 aut | |
700 | 1 | |a Huertas Marín, Carmen |e verfasserin |4 aut | |
700 | 1 | |a Dierssen-Soto, Trinidad |e verfasserin |4 aut | |
700 | 1 | |a Fernández, Alba |e verfasserin |4 aut | |
700 | 1 | |a Ferrero-Franco, Raquel |e verfasserin |4 aut | |
700 | 1 | |a González-Castro, Alejandro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicina clinica |d 1948 |g 161(2023), 5 vom: 08. Sept., Seite 199-204 |w (DE-627)NLM000359017 |x 1578-8989 |7 nnns |
773 | 1 | 8 | |g volume:161 |g year:2023 |g number:5 |g day:08 |g month:09 |g pages:199-204 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medcli.2023.04.022 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 161 |j 2023 |e 5 |b 08 |c 09 |h 199-204 |